VIVO BIO TECH
|
|
BOM : 511509     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : NA |
May 25,2022 |
Price(EOD): ₹ 37.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Miscellaneous |
MCap: ₹ 56.25 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
VIVO BIO TECH | -2.8% | -5.6% | -37.7% |
SYNGENE INTERNATIONAL | -2.6% | -16.5% | -4.2% |
QUESS CORP | 3.9% | -3.5% | -0% |
SUN PHARMA ADVANCED RESEARCH COMPANY | -1.8% | -19.7% | -1.7% |
TEAMLEASE SERVICES | -2.9% | -17.7% | -1.3% |
SECURITY AND INTELLIGENCE SERVICES INDIA | -4.8% | -9.2% | 14.9% |
JUST DIAL | -4.1% | -21.9% | -14.2% |
DELTA CORP | -7.4% | -22.4% | 43.1% |
HEALTHCARE GLOBAL ENTERPRISES | 1.2% | -5.9% | 47.9% |
FUNDAMENTAL ANALYSIS OF VIVO BIO TECH
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF VIVO BIO TECH
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
8.92
P/E Calculated based on EPS of 4.23
[ Mar2021 - Consolidated Results ] 1.23
P/B Calculated based on Book Value of 30.58
[ Mar2021 - Consolidated Results ] 1.08
P/S Calculated based on Revenues of 52.166 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
1% -19% -17% |
SHARE PRICE MOMENTUM OF VIVO BIO TECH
VIVO BIO TECH vs SENSEX
DEBT OF VIVO BIO TECH
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.7 0.67 0.81 0.73 |
0.75 0.74 0.81 0.77 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF VIVO BIO TECH
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF VIVO BIO TECH
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
27.07% 107.88% 166.42% 394.95% |
8.8% 20.28% -2.1% -38.44% |
QtrlyTrend |
4 | |
Latest Qtr: Dec2021 | ||
Quarterly Result Analysis → |
VIVO BIO TECH related INDICES
You may also like the below Video Courses
FAQ about VIVO BIO TECH
Is VIVO BIO TECH good for long term investment?
As on May 25,2022, the Fundamentals of VIVO BIO TECH look Poor and hence it may not be good for long term investment ! See Financial Performance of VIVO BIO TECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is VIVO BIO TECH UnderValued or OverValued?
As on May 25,2022, VIVO BIO TECH is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of VIVO BIO TECH ?
As on May 25,2022, the Intrinsic Value of VIVO BIO TECH is Rs. 45.52 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 37.28
Fair Value [Median EV / Sales Model] : Rs. 46.70
Fair Value [Median Price / Sales Model] : Rs. 45.52
Median Fair Value of VIVO BIO TECH : Rs. 45.52
Is VIVO BIO TECH trading at a Premium or Discount?
As on May 25,2022, VIVO BIO TECH is trading at a Discount of -17% based on the estimates of Median Intrinsic Value!SYNGENE INTERNATIONAL LTD vs QUESS CORP LTD vs SUN PHARMA ADVANCED RESEARCH COMPANY LTD
TEAMLEASE SERVICES LTD vs SIS LTD vs JUST DIAL LTD
DELTA CORP LTD vs HEALTHCARE GLOBAL ENTERPRISES LTD vs VA TECH WABAG LTD
BLS INTERNATIONAL SERVICES LTD vs SAFARI INDUSTRIES (INDIA) LTD vs EKI ENERGY SERVICES LTD
ANTONY WASTE HANDLING CELL LTD vs YAARII DIGITAL INTEGRATED SERVICES LTD vs SANGHVI MOVERS LTD
